CovalX is the leading provider of protein interactions analysis by mass spectrometry.
We offer several unique analytical services based upon our novel high mass detection technology, including.
Large Molecule (up to 2 Megadaltons) and Intact Protein Complex Detection by Mass Spectrometry
Hydrogen Deuterium eXchange (HDX) for Higher Order Structure Determination
Crosslinking Mass Spec (XL-MS) for Conformational Epitope Mapping
Analysis of membrane bound Proteins with Mass Spectrometry
CovalX AG was founded in 2006. The company's vision is to become a leading provider of
technology and services in the field of protein interaction analysis based on mass spectrometry.
With support offices in Switzerland, France and USA, CovalX is a global company offering
leading product and services for major pharmaceutical companies as well as academic
laboratories.
